157 related articles for article (PubMed ID: 34652135)
1. Visualization of Receptor-Interacting Protein Kinase 1 (RIPK1) by Brain Imaging with Positron Emission Tomography.
Lan Y; Bai P; Liu Y; Afshar S; Striar R; Rattray AK; Meyer TN; Langan AG; Posner AM; Shen S; Tanzi RE; Zhang C; Wang C
J Med Chem; 2021 Oct; 64(20):15420-15428. PubMed ID: 34652135
[TBL] [Abstract][Full Text] [Related]
2. Development of a New Positron Emission Tomography Imaging Radioligand Targeting RIPK1 in the Brain and Characterization in Alzheimer's Disease.
Bai P; Lan Y; Liu Y; Mondal P; Gomm A; Xu Y; Wang Y; Wang Y; Kang L; Pan L; Bagdasarian FA; Hallisey M; Varela B; Choi SH; Gomperts SN; Wey HY; Shen S; Tanzi RE; Wang C; Zhang C
Adv Sci (Weinh); 2024 Jun; ():e2309021. PubMed ID: 38923244
[TBL] [Abstract][Full Text] [Related]
3. Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3.
Chen X; Zhuang C; Ren Y; Zhang H; Qin X; Hu L; Fu J; Miao Z; Chai Y; Liu ZG; Zhang H; Cai Z; Wang HY
Br J Pharmacol; 2019 Jun; 176(12):2095-2108. PubMed ID: 30825190
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity.
Li Z; Hao Y; Yang C; Yang Q; Wu S; Ma H; Tian S; Lu H; Wang J; Yang T; He S; Zhang X
Eur J Med Chem; 2022 Jan; 228():114036. PubMed ID: 34906762
[TBL] [Abstract][Full Text] [Related]
5. Development and biological evaluation of[
Malik N; Kornelsen R; McCormick S; Colpo N; Merkens H; Bendre S; Benard F; Sossi V; Schirrmacher R; Schaffer P
Eur J Med Chem; 2021 Feb; 211():113005. PubMed ID: 33248850
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant and food additive BHA prevents TNF cytotoxicity by acting as a direct RIPK1 inhibitor.
Delanghe T; Huyghe J; Lee S; Priem D; Van Coillie S; Gilbert B; Choi SM; Vandenabeele P; Degterev A; Cuny GD; Dondelinger Y; Bertrand MJM
Cell Death Dis; 2021 Jul; 12(7):699. PubMed ID: 34262020
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of a novel PET ligand, a GSK'963 analog, aiming at autoradiography and imaging of the receptor interacting protein kinase 1 in the brain.
Ikenuma H; Ogata A; Koyama H; Ji B; Ishii H; Yamada T; Abe J; Seki C; Nagai Y; Ichise M; Minamimoto T; Higuchi M; Zhang MR; Kato T; Ito K; Suzuki M; Kimura Y
EJNMMI Radiopharm Chem; 2023 Oct; 8(1):31. PubMed ID: 37853253
[TBL] [Abstract][Full Text] [Related]
8.
Zhang H; Xu L; Qin X; Chen X; Cong H; Hu L; Chen L; Miao Z; Zhang W; Cai Z; Zhuang C
J Med Chem; 2019 Jul; 62(14):6665-6681. PubMed ID: 31095385
[TBL] [Abstract][Full Text] [Related]
9. Identification of 5-(2,3-Dihydro-1 H-indol-5-yl)-7 H-pyrrolo[2,3- d]pyrimidin-4-amine Derivatives as a New Class of Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors, Which Showed Potent Activity in a Tumor Metastasis Model.
Li Y; Xiong Y; Zhang G; Zhang L; Yang W; Yang J; Huang L; Qiao Z; Miao Z; Lin G; Sun Q; Niu T; Chen L; Niu D; Li L; Yang S
J Med Chem; 2018 Dec; 61(24):11398-11414. PubMed ID: 30480444
[TBL] [Abstract][Full Text] [Related]
10. Ring closure strategy leads to potent RIPK3 inhibitors.
Wu S; Xu C; Xia K; Lin Y; Tian S; Ma H; Ji Y; Zhu F; He S; Zhang X
Eur J Med Chem; 2021 May; 217():113327. PubMed ID: 33730678
[TBL] [Abstract][Full Text] [Related]
11. Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitis.
Le Cann F; Delehouzé C; Leverrier-Penna S; Filliol A; Comte A; Delalande O; Desban N; Baratte B; Gallais I; Piquet-Pellorce C; Faurez F; Bonnet M; Mettey Y; Goekjian P; Samson M; Vandenabeele P; Bach S; Dimanche-Boitrel MT
FEBS J; 2017 Sep; 284(18):3050-3068. PubMed ID: 28715128
[TBL] [Abstract][Full Text] [Related]
12. 6E11, a highly selective inhibitor of Receptor-Interacting Protein Kinase 1, protects cells against cold hypoxia-reoxygenation injury.
Delehouzé C; Leverrier-Penna S; Le Cann F; Comte A; Jacquard-Fevai M; Delalande O; Desban N; Baratte B; Gallais I; Faurez F; Bonnet MC; Hauteville M; Goekjian PG; Thuillier R; Favreau F; Vandenabeele P; Hauet T; Dimanche-Boitrel MT; Bach S
Sci Rep; 2017 Oct; 7(1):12931. PubMed ID: 29018243
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and preclinical evaluation of
Luo T; Sang N; Liu Y; Zhou Y; Wu R; Bagdasarian FA; Wey HY; Lang J; Wang C; Bai P
Bioorg Chem; 2024 May; 146():107279. PubMed ID: 38513325
[TBL] [Abstract][Full Text] [Related]
14. Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives.
Zhuang C; Chen F
J Med Chem; 2020 Feb; 63(4):1490-1510. PubMed ID: 31622096
[TBL] [Abstract][Full Text] [Related]
15. The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinases.
Qin X; Hu L; Shi SN; Chen X; Zhuang C; Zhang W; Jitkaew S; Pang X; Yu J; Tan YX; Wang HY; Cai Z
Biochem Pharmacol; 2020 Jul; 177():113947. PubMed ID: 32247850
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of keratinocyte necroptosis mediated by RIPK1/RIPK3/MLKL provides a protective effect against psoriatic inflammation.
Duan X; Liu X; Liu N; Huang Y; Jin Z; Zhang S; Ming Z; Chen H
Cell Death Dis; 2020 Feb; 11(2):134. PubMed ID: 32075957
[TBL] [Abstract][Full Text] [Related]
17. RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress.
Wang JN; Liu MM; Wang F; Wei B; Yang Q; Cai YT; Chen X; Liu XQ; Jiang L; Li C; Hu XW; Yu JT; Ma TT; Jin J; Wu YG; Li J; Meng XM
Clin Sci (Lond); 2019 Jul; 133(14):1609-1627. PubMed ID: 31315969
[TBL] [Abstract][Full Text] [Related]
18. The multitargeted kinase inhibitor KW-2449 ameliorates cisplatin-induced nephrotoxicity by targeting RIPK1-mediated necroptosis.
Rui C; Shi SN; Ren W; Qin X; Zhuang C; Chen X; Chen G; Yu J; Wang HY; Cai Z
Biochem Pharmacol; 2021 Jun; 188():114542. PubMed ID: 33819469
[TBL] [Abstract][Full Text] [Related]
19. Identification and Characterization of NTB451 as a Potential Inhibitor of Necroptosis.
In EJ; Lee Y; Koppula S; Kim TY; Han JH; Lee KH; Kang TB
Molecules; 2018 Nov; 23(11):. PubMed ID: 30400632
[TBL] [Abstract][Full Text] [Related]
20. Critical contribution of oxidative stress to TNFα-induced necroptosis downstream of RIPK1 activation.
Shindo R; Kakehashi H; Okumura K; Kumagai Y; Nakano H
Biochem Biophys Res Commun; 2013 Jun; 436(2):212-6. PubMed ID: 23727581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]